Quality Product Research: Research Advisory Board – Central

We recently held our first Research Advisory Board meeting of the year with our Central Representatives and as usual received a lot of feedback to bring back to our team.

Independent Chair: Tony Dench

Insurer Observers: Amanda Harlen (Asteron Life), Helena Harbrow (Partners Life)

Board members: Samuel Rees-Thomas, Louise Grinstead, Joshua Logan (stepping down)

QPR Representatives: Russell Hutchinson, Doreen Dutt

The research advisory board reviewed the following topics:

·        Research report design, specifically a revamp of our Summary and Detailed Head-to-Head report to provide more details

·        Allowing for more flexibility in how advisers can present reports.

·        A review of our current trauma buyback options, we propose including an additional button, Buyback + Instant Buyback under the trauma Advanced Options and once selected, the best of the two scores will be quoted and displayed in the research.  

·        The proposed rating for non-PHARMAC, recently we created an infographic comparing non-PHARMAC medicines between providers and we will use this to revise the rating for this benefit within medical.

The feedback from our Research Advisory Board meetings has overall been very valuable to our research team and allows us to strengthen our research ratings when we gain an insight into the adviser perspective.

Since the meeting we have the news that Josh Logan is stepping aside from the role for the time being, we thank Josh for his service and look forward to inviting him back at some point in the future.

If you’re interested in providing feedback on any of the topics above, please reach out to our research team on info@quotemonster.co.nz or join us for our research deep dive scheduled for Thursday, 19 September 2024 11:30 am-12:30 pm.

We look forward to visiting our Southern team later this year.  

For more information on our Research Advisory board please click here.